妊娠中の糖尿病の診断とリスクの階層化における臓ベータ細胞分泌産物:前向きな長期コホート研究
Gareth Dunseath1, Michael Atkinson2, Wai-Yee Cheung3
1Diabetes Research Group, Swansea University Faculty of Medicine Health and Life Science, Swansea, Wales, UK g.j.dunseath@swansea.ac.uk.
BMJ open
|September 5, 2025
まとめ
妊娠初期におけるCペプチドレベルは,妊娠糖尿病 (GDM) の予測に役立つ. プロインスリンは違いを示さなかったが,Cペプチドの濃度は,GDMを発症した女性と正常なグルコース耐性を維持した女性間で異なっていた.
科学分野:
- 内分泌学
- 生殖医学
- 代謝障害
背景:
- 妊娠中糖尿病 (GDM) の罹患率は増加しており,母親と胎児の健康にリスクをもたらしています.
- 現在のGDMの診断は,経口グルコース耐性検査 (OGTT) によるもので,合併症がすでに発生している可能性があります.
- GDMのリスクを早期に発見することは,適切な介入と改善された結果にとって極めて重要です.
研究 の 目的:
- 妊娠初期ベータ細胞分泌剤がGDMの予測マーカーとして機能するかどうかを調査する.
- 妊娠初期にホルモンの濃度を評価し,GDMを発症する女性と正常なグルコース耐性を維持する女性を区別する.
- GDMの早期診断マーカーとしてプロインスリンとCペプチドの可能性を調査する.
主な方法:
- GDMの危険因子を持つ妊婦を対象とした前向きな長期コホート研究.
- 経口グルコース耐性検査 (OGTT) とグルコース,プロインスリン,インスリン,Cペプチドの血液採取は妊娠16~18週と24~28週に行われました.
- GDMを発症した女性と正常なグルコース耐性を維持した女性のホルモン濃度を比較するために,受容器操作者特性 (ROC) 分析を使用した.
主要な成果:
- 66人の参加者のデータを分析し,15人はGDMに進行し,51人は正常なグルコース耐性を維持した.
- グループ間では,プロインスリンとインスリン全量/無傷の ROC 領域 (AUC) の有意な差異は認められなかった.
- 妊娠初期30分 (p=0. 041) と60分 (p=0. 003) で,CペプチドROCAUCの有意な差異が観察されました.
結論:
- 妊娠初期におけるプロインスリン濃度は,GDMの発症を有意に予測しなかった.
- 妊娠初期におけるCペプチド濃度は,GDMを発症した女性と発症しなかった女性の潜在的差異を示した.
- COVID-19 パンデミックによるサンプルサイズが限られているため,初期のGDMマーカーとしてCペプチドに関するこれらの発見を検証するために,より大きな研究が必要である.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K


